Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score 20.38
- Piotroski Score 4.00
- Grade Hold
- Symbol (AXNX)
- Company Axonics, Inc.
- Price $70.98
- Changes Percentage (0%)
- Change -$0
- Day Low $70.98
- Day High $70.98
- Year High $71.05
Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention. Its proprietary rechargeable SNM System (r-SNM) delivers mild electrical pulses to the targeted sacral nerve to restore normal communication to and from the brain to reduce the symptoms of bladder and bowel dysfunction. The company also offers Bulkamid, a urethral bulking agent to treat female stress urinary incontinence. It sells its products through a direct salesforce and distributors in the United States, the United Kingdom, Germany, the Netherlands, Nordic countries, and internationally. The company was formerly known as Axonics Modulation Technologies, Inc. and changed its name to Axonics, Inc. in March 2021. Axonics, Inc. was incorporated in 2012 and is based in Irvine, California.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 11/07/2024
- Fiscal Year End N/A
- Average Stock Price Target $71.00
- High Stock Price Target $71.00
- Low Stock Price Target $71.00
- Potential Upside/Downside N/A
- Consensus Rating Strong Sell
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$0.31
- Trailing P/E Ratio -216.39
- Forward P/E Ratio -216.39
- P/E Growth -216.39
- Net Income $-6,088,000
Income Statement
Quarterly
Annual
Latest News of AXNX
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Axonics, Inc. (AXNX): Strong Growth and Global Momentum in 2024
George Soros, a prominent investor and philanthropist, has a net worth of $7.2 billion. His top holdings include Axonics, Inc. (NASDAQ:AXNX), a medical technology company specializing in treatments fo...
By Yahoo! Finance | 1 month ago
